Type 2 diabetes mellitus. E08
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Confirmation of Type 2 Diabetes (Fasting blood glucose greater than 126 mg/dL, Oral glucose tolerance test equal to or greater than 200 mg/dL, A1C level of 6.5 percent or higher)BMI 28-35Age between 45-55years
Exclusion criteria
Exclusion criteria: Use insulin Having cardiovascular diseases, musculoskeletal disorders, liver disease, kidney disease, thyroid dysfunction Having regular physical activity in at least the last six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fibroblast Growth Factor 21 (FGF21). Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: ELISA method.;Irisin. Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: ELISA method.;Myostatin (MSTN). Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: ELISA method.;HbA1C. Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: Nyco Card device.;Insulin resistance. Timepoint: Before the intervention and 48 hours after the end of intervention. Method of measurement: HOMA-IR method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Artesh University of Medical Sciences